Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

King Faisal Specialist Hospital & Research Center

Status and phase: Unknown; Phase 1

Conditions: Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Treatments: Drug: Mycophenolate Mofetil

Study type: Interventional

Funder types: Other

Identifiers

NCT00531635

RAC#2001-051

Details and patient eligibility

About

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil

Enrollment: 350 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients receiving Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil.

Exclusion criteria

• Uncontrolled major medical illnesses

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)